KR102520887B1 - Cosmetic composition for UV protection comprising porous composites - Google Patents
Cosmetic composition for UV protection comprising porous composites Download PDFInfo
- Publication number
- KR102520887B1 KR102520887B1 KR1020220099163A KR20220099163A KR102520887B1 KR 102520887 B1 KR102520887 B1 KR 102520887B1 KR 1020220099163 A KR1020220099163 A KR 1020220099163A KR 20220099163 A KR20220099163 A KR 20220099163A KR 102520887 B1 KR102520887 B1 KR 102520887B1
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- porous composite
- porous
- titanium dioxide
- sunscreen
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 58
- 239000002537 cosmetic Substances 0.000 title claims abstract description 47
- 239000002131 composite material Substances 0.000 title claims abstract description 41
- 230000006750 UV protection Effects 0.000 title 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 52
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 16
- 239000002245 particle Substances 0.000 claims abstract description 15
- 239000011148 porous material Substances 0.000 claims abstract description 14
- 239000000516 sunscreening agent Substances 0.000 claims description 30
- 230000000475 sunscreen effect Effects 0.000 claims description 28
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000377 silicon dioxide Substances 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 3
- 238000009472 formulation Methods 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 8
- 229940059958 centella asiatica extract Drugs 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000000704 physical effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 230000000903 blocking effect Effects 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 4
- 239000004926 polymethyl methacrylate Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Natural products OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 2
- 239000007771 core particle Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 230000004224 protection Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- QULIOZDJZXKLNY-UHFFFAOYSA-N 3,4,5-trihydroxy-2-propylbenzoic acid Chemical compound CCCC1=C(O)C(O)=C(O)C=C1C(O)=O QULIOZDJZXKLNY-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 1
- 101000990902 Homo sapiens Matrix metalloproteinase-9 Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 description 1
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 241000862632 Soja Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- FKIQSOGFDBALHA-UHFFFAOYSA-L aluminum trimagnesium potassium dioxido(oxo)silane oxygen(2-) difluoride Chemical compound [O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[K+].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O FKIQSOGFDBALHA-UHFFFAOYSA-L 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000011162 core material Substances 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000002649 leather substitute Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 1
- 229940011656 madecassic acid Drugs 0.000 description 1
- BUWCHLVSSFQLPN-UHFFFAOYSA-N madecassic acid Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(=O)O)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O BUWCHLVSSFQLPN-UHFFFAOYSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- -1 polyquaternium-7 Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000037072 sun protection Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
- A61K8/0279—Porous; Hollow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 다공성 복합체를 포함하는 자외선 차단용 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for sunscreen comprising a porous composite.
자외선은 주름, 멜라닌 형성을 촉진하는 등, 피부 노화를 일으키는 주된 원인으로 알려져 있고, 자외선을 효과적으로 차단하기 위한 다양한 화장품이 개발되고 있다. 종래 수중유형(O/W) 제품이 많이 사용되었으나, 이는 땀이나 물에 약하여 수영, 등산 등과 같이, 땀이나 물에 노출되기 쉬운 환경에서 사용되기에 부적절하다. 이러한 문제를 해결하기 위하여 티타늄 디옥사이드, 징크 옥사이드 등의 무기 자외선 차단제를 사용하는 제품이 널리 사용되고 있다.UV rays are known to be the main cause of skin aging, such as promoting wrinkles and melanin formation, and various cosmetics are being developed to effectively block UV rays. Conventional underwater type (O / W) products have been widely used, but they are weak against sweat or water, so they are not suitable for use in environments where they are easily exposed to sweat or water, such as swimming or mountain climbing. In order to solve this problem, products using inorganic sunscreens such as titanium dioxide and zinc oxide are widely used.
티타늄 디옥사이드는 빛을 흡수, 반사, 산란하는 효과가 우수하여 무기 자외선 차단제로 주로 사용되나, 이를 포함하는 제품에서는 백탁 현상이 두드러지게 나타나는 문제가 있고, 또한, 티타늄 디옥사이드가 피부의 모공 내에 축적되는 문제가 있다. 한편, 이러한 문제를 해결하기 위하여 나노 입자 크기의 티타늄 디옥사이드가 사용되기도 하였으나, 나노 사이즈의 티타늄 디옥사이드 입자를 장기간 흡입하였을 때 폐암과 같은 호흡기계 질환들이 발생할 수 있다는 연구 결과가 발표되면서, 이를 포함하는 화장품에 대한 안전성 문제가 대두되기 시작하였다. Titanium dioxide is mainly used as an inorganic sunscreen because of its excellent effect of absorbing, reflecting, and scattering light, but products containing it have a problem in that the cloudiness phenomenon is prominent, and titanium dioxide is accumulated in the pores of the skin. there is On the other hand, nano-sized titanium dioxide has been used to solve this problem, but as research results have been published that respiratory diseases such as lung cancer can occur when inhaling nano-sized titanium dioxide particles for a long time, cosmetics containing it Safety issues began to emerge.
이에, 종래 무기 자외선 차단제의 백탁 현상을 줄이고, 안전한 동시에, 우수한 자외선 차단 성능 및 사용감을 지니는 무기 자외선 차단제가 요구된다. Accordingly, there is a need for inorganic sunscreens that reduce cloudiness of conventional inorganic sunscreens, are safe, and have excellent sunscreen performance and a feeling of use.
본 발명은 자외선 차단 성능, 사용감 및 안정성이 우수하고, 백탁 현상이 감소된 자외선 차단용 화장료 조성물을 제공한다. The present invention provides a cosmetic composition for sunscreen with excellent sunscreen performance, feeling of use and stability, and reduced cloudiness.
본 발명은 코어에 티타늄 디옥사이드를 부착하여 제조된 다공성 입자의 기공 내에 천연 추출물을 포함하는 다공성 복합체를 포함하는 자외선 차단용 화장료 조성물을 제공한다.The present invention provides a cosmetic composition for sunscreen comprising a porous composite containing a natural extract in the pores of porous particles prepared by attaching titanium dioxide to a core.
본 발명의 자외선 차단용 화장료 조성물은 자외선 차단 성능, 사용감 및 안정성이 우수하고, 백탁 현상을 최소화하는 동시에 무기 자외선 차단제가 모공 내에 축적되는 것을 방지할 수 있다. 또한, 본 발명에 따른 다공성 복합체는 기공 내에 항노화, 항염 효과를 지니는 유효 성분을 포함하므로, 자외선 차단과 동시에 피부를 보호하는 역할을 한다.The cosmetic composition for sunscreen of the present invention has excellent sunscreen performance, feeling of use, and stability, and can prevent inorganic sunscreen agents from accumulating in pores while minimizing cloudiness. In addition, since the porous composite according to the present invention contains active ingredients having anti-aging and anti-inflammatory effects in the pores, it serves to protect the skin at the same time as blocking ultraviolet rays.
이하, 본 발명에 대하여 설명한다. 그러나, 하기 내용에 의해서만 한정되는 것은 아니며, 필요에 따라 각 구성요소가 다양하게 변형되거나 선택적으로 혼용될 수 있다. 따라서, 본 발명의 사상 및 기술범위에 포함되는 모든 변경, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다.Hereinafter, the present invention will be described. However, it is not limited only by the following contents, and each component may be variously modified or selectively mixed as needed. Therefore, it should be understood to include all modifications, equivalents or substitutes included in the spirit and scope of the present invention.
본 발명의 자외선 차단용 화장료 조성물은 코어에 티타늄 디옥사이드를 부착하여 제조된 다공성 입자의 기공 내에 천연 추출물을 포함하는 다공성 복합체를 포함한다. 또한, 본 발명의 자외선 차단용 화장료 조성물은 계면활성제, 산화방지제, 방부제, 보습제, 윤활제 등, 화장품에 통상 사용되는 성분을 더 포함할 수 있다. The cosmetic composition for sunscreen of the present invention includes a porous composite containing a natural extract in the pores of porous particles prepared by attaching titanium dioxide to a core. In addition, the cosmetic composition for sunscreen of the present invention may further include ingredients commonly used in cosmetics, such as surfactants, antioxidants, preservatives, humectants, and lubricants.
다공성 복합체porous composite
본 발명의 자외선 차단용 화장료 조성물은 다공성 복합체를 포함한다. 상기 다공성 복합체는 코어에 티타늄 디옥사이드를 부착하여 제조된 다공성 입자의 기공 내에 천연 추출물을 포함한다. 본 발명의 다공성 복합체는 안정적인 제형을 형성할 수 있고, 자외선 차단과 동시에 자외선으로부터 손상된 피부를 보호하는 효과를 발휘한다.The cosmetic composition for sunscreen of the present invention includes a porous composite. The porous composite includes a natural extract in the pores of porous particles prepared by attaching titanium dioxide to the core. The porous composite of the present invention can form a stable formulation, and exhibits an effect of protecting damaged skin from ultraviolet rays at the same time as blocking ultraviolet rays.
상기 코어로는 실리카, 폴리메틸메타아크릴레이트(PMMA), 마이카, 합성 플루오로플로고파이트(fluorphlogopite) 등을 사용할 수 있다. 상기 코어 입자의 평균 직경은 2 내지 10 ㎛일 수 있다. 상기 코어 입자의 평균 직경이 전술한 범위를 벗어나는 경우, 안정도가 저하될 수 있다.As the core, silica, polymethyl methacrylate (PMMA), mica, synthetic fluorophlogopite, and the like may be used. The average diameter of the core particles may be 2 to 10 μm. When the average diameter of the core particles is out of the above range, stability may be deteriorated.
상기 티타늄 디옥사이드 입자는 평균 직경이 0.1 내지 1 ㎛이고, 흡유량이 1.0 ± 0.5 내지 15.0 ± 0.5 ml/100g일 수 있다. 상기 티타늄 디옥사이드 입자의 평균 직경 및 흡유량이 전술한 범위를 벗어나는 경우, 안정도가 저하될 수 있다.The titanium dioxide particles may have an average diameter of 0.1 to 1 μm and an oil absorption of 1.0 ± 0.5 to 15.0 ± 0.5 ml/100g. When the average diameter and oil absorption of the titanium dioxide particles are out of the above ranges, stability may be deteriorated.
상기 코어에 티타늄 디옥사이드를 부착하여 다공성 입자를 제조한다. 일례로, 스프레이 드라이 방법을 사용하여, 상기 코어에 티타늄 디옥사이드를 부착할 수 있다. 티타늄 디옥사이드는 다공성 복합체 총량을 기준으로 30 내지 80 중량%, 예를 들어 40 내지 65 중량% 포함될 수 있다. 상기 다공성 입자에 생성된 기공의 평균 직경은 0.1 내지 3 ㎛일 수 있다. 상기 기공의 평균 직경이 전술한 범위를 벗어나는 경우, 안정도가 저하될 수 있다.Titanium dioxide is attached to the core to prepare porous particles. For example, titanium dioxide may be attached to the core using a spray drying method. Titanium dioxide may be included in an amount of 30 to 80% by weight, for example, 40 to 65% by weight based on the total weight of the porous composite. An average diameter of pores generated in the porous particle may be 0.1 to 3 μm. When the average diameter of the pores is out of the above range, stability may be deteriorated.
상기 다공성 입자에 생성된 기공에 천연 추출물을 담지시켜 본 발명의 다공성 복합체를 제조한다. 상기 천연 추출물로는 항염, 항노화, 미백, 항산화 효과를 갖는 물질을 제한없이 사용할 수 있고, 특히 자외선에 대한 세포 보호 기능이 우수하여 세포의 사멸을 억제하고, 세포 독성을 유발하지 않으며, 자외선으로 유도된 피부 염증의 완화 효과 및 이로 인한 MMP1, MMP9, TNF-a의 유전자 발현을 저해하는 효능 등이 뛰어난 물질을 사용할 수 있다. 예를 들어, 상기 천연 추출물로는 병풀 추출물, 석창포 추출물, 소자 추출물, 연꽃 추출물, 인삼 추출물 등을 사용할 수 있다.The porous composite of the present invention is prepared by supporting a natural extract in the pores formed in the porous particles. As the natural extract, substances having anti-inflammatory, anti-aging, whitening, and antioxidant effects can be used without limitation, and in particular, the cell protection function against ultraviolet rays is excellent, so that cell death is inhibited, cytotoxicity is not caused, and ultraviolet rays Substances having an excellent effect of alleviating induced skin inflammation and thereby inhibiting gene expression of MMP1, MMP9, and TNF-a may be used. For example, as the natural extract, centella asiatica extract, seokchangpo extract, soja extract, lotus extract, ginseng extract and the like can be used.
일례로, 상기 천연 추출물은 병풀 추출물일 수 있다. 병풀 추출물은 아시아틱애씨드, 마데카식애씨드, 아시아티코사이드를 포함하는 것으로, 염증 반응을 줄이고, 피부 콜라겐과 피브로텍틴과 같은 당단백질을 증가시켜 상처 치유에 효과적인 물질이다. 또한, 병풀 추출물은 광노화 방지에 도움이 되고, 자외선을 과도하게 받아 노화된 피부 표피층을 복구하는데 효과적이다. 다만, 병풀 추출물은 화장품에 적용 시, 파우더가 석출되는 현상이 많이 나타나 고농축 파우더를 화장품 제형에 적용하기 어려운 문제가 있었다. 본 발명에서는 병풀 추출물을 에탄올 등의 용매에 용해한 후, 상기 다공성 입자의 기공에 함침시킴으로서, 석출이 방지되는 안정적인 제형을 형성할 수 있다. For example, the natural extract may be centella asiatica extract. Centella asiatica extract contains asiatic acid, madecassic acid, and asiaticoside, and is an effective substance for wound healing by reducing inflammatory reactions and increasing glycoproteins such as skin collagen and fibrotectin. In addition, centella asiatica extract helps to prevent photoaging and is effective in restoring the skin's epidermal layer aged by excessive exposure to ultraviolet rays. However, when the centella asiatica extract was applied to cosmetics, there was a problem in that it was difficult to apply the highly concentrated powder to the cosmetic formulation because a lot of the powder was precipitated. In the present invention, a stable formulation in which precipitation is prevented can be formed by dissolving the centella asiatica extract in a solvent such as ethanol and then impregnating the pores of the porous particles.
상기 천연 추출물은 다공성 복합체 총량을 기준으로 0.1 내지 10 중량% 포함될 수 있다. 천연 추출물의 함량이 전술한 범위 미만인 경우 자외선 차단 및 손상된 피부 회복 효과가 불충분할 수 있고, 전술한 범위를 초과하는 경우 안정도가 저하될 수 있다.The natural extract may be included in an amount of 0.1 to 10% by weight based on the total amount of the porous composite. When the content of the natural extract is less than the above-mentioned range, sunscreen and damaged skin recovery effects may be insufficient, and when it exceeds the above-mentioned range, stability may be deteriorated.
상기 다공성 복합체의 평균 직경은 10 내지 30 ㎛일 수 있다.An average diameter of the porous composite may be 10 to 30 μm.
상기 다공성 복합체는 화장료 조성물 총량을 기준으로 0.1 내지 15 중량% 포함될 수 있다. 다공성 복합체의 함량이 전술한 범위 미만인 경우 자외선 차단 효과가 불충분할 수 있고, 전술한 범위를 초과하는 경우 분산력 및 사용감이 열세해질 수 있다.The porous composite may be included in an amount of 0.1 to 15% by weight based on the total amount of the cosmetic composition. If the content of the porous composite is less than the above range, the UV blocking effect may be insufficient, and if it exceeds the above range, dispersibility and feeling of use may be poor.
기타 성분Other Ingredients
상기 자외선 차단용 화장료 조성물은 계면활성제, 산화방지제, 방부제, 보습제, 윤활제 등의 성분을 더 첨가할 수 있다. Components such as surfactants, antioxidants, preservatives, humectants, and lubricants may be further added to the cosmetic composition for sunscreen.
상기 계면활성제로는 음이온계 계면활성제, 양이온계 계면활성제, 양상 계면활성제, 비이온성 계면활성제 등을 사용할 수 있다. 예를 들어, 글리세릴 스테아레이트, 폴리소르베이트20, 포타슘 세틸 포스페이트, 레시틴, 소르비탄 세스퀴올리에이트, 폴리글리세릴류 등을 사용할 수 있다.As the surfactant, anionic surfactants, cationic surfactants, amphoteric surfactants, nonionic surfactants, and the like may be used. For example, glyceryl stearate, polysorbate 20, potassium cetyl phosphate, lecithin, sorbitan sesquioleate, polyglyceryls and the like can be used.
상기 산화방지제로는 부틸히드록시아니솔, 갈릭산프로필, 엘리소르빈산 등을 사용할 수 있다.As the antioxidant, butylhydroxyanisole, propyl gallic acid, elisorbic acid, and the like may be used.
상기 방부제로는 페녹시에탄올, 에탄올, 펜틸렌글라이콜, 헥산디올, 에칠헥실글리세린, 카프릴릴글라이콜, 글리세린, 부틸렌글라이콜, 프로필렌글라이콜, 아세트산(acetic acid), 부티르산(butyric acid), 시트르산(citric acid), 팔미트산(palmitic acid), 옥살산(oxalic acid), 타타르산(tartaric acid), 글리콜산(glycolic acid), 락트산(lactic acid), 말레산(maleic acid)], 디포타슘글리시리제이트 등을 사용할 수 있다.The above preservatives include phenoxyethanol, ethanol, pentylene glycol, hexanediol, ethylhexyl glycerin, caprylyl glycol, glycerin, butylene glycol, propylene glycol, acetic acid, butyric acid ), citric acid, palmitic acid, oxalic acid, tartaric acid, glycolic acid, lactic acid, maleic acid], Dipotassium glycyrrhizate etc. can be used.
상기 보습제로는 글리세린, 프로필렌, 부틸렌글리콜 등의 폴리올, 포도당, 트레할로스, 자일리톨, 에리스리톨 등의 당류 등을 사용할 수 있다. As the moisturizing agent, polyols such as glycerin, propylene, and butylene glycol, sugars such as glucose, trehalose, xylitol, and erythritol may be used.
상기 점증제로는 셀룰로오스검, 잔탄검, 아가, 타마린드검, 구아검, 아라비아검, 세틸알코올, 스테아릴알코올, 세테아릴알코올, 소듐클로라이드, 폴리쿼터늄-7, 카보머 등을 사용할 수 있다.As the thickener, cellulose gum, xanthan gum, agar, tamarind gum, guar gum, gum arabic, cetyl alcohol, stearyl alcohol, cetearyl alcohol, sodium chloride, polyquaternium-7, carbomer, etc. may be used. .
본 발명의 화장료 조성물은 해당 기술분야에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 오일, 분말, 왁스, 스틱 및 스프레이 등의 제형으로 제조될 수 있다.The cosmetic composition of the present invention can be prepared in any formulation commonly prepared in the art, for example, solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, oils, powders, waxes, It can be prepared in formulations such as sticks and sprays.
본 발명의 화장료 조성물은 해당 기술분야에 공지된 다양한 방법에 따라 제조될 수 있다. The cosmetic composition of the present invention can be prepared according to various methods known in the art.
이하, 실시예를 통하여 본 발명을 보다 구체적으로 설명한다. 그러나, 하기 실시예는 본 발명의 이해를 돕기 위한 것일 뿐 어떠한 의미로든 본 발명의 범위가 실시예로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail through examples. However, the following examples are only for facilitating the understanding of the present invention, and the scope of the present invention is not limited to the examples in any sense.
[제조예 1-5: 다공성 복합체 제조] [Preparation Example 1-5: Preparation of Porous Composite]
하기 표 1의 조성에 따라, 코어(실리카)에 티타늄 디옥사이드를 부착하여 제조된 다공성 입자의 기공 내에 천연 추출물(병풀 추출물)을 포함하는 각 제조예의 다공성 복합체를 제조하였다.According to the composition of Table 1 below, a porous composite of each preparation example containing a natural extract (centella asiatica extract) in the pores of porous particles prepared by attaching titanium dioxide to a core (silica) was prepared.
[실험예 1-6: 수중유형 화장료 조성물 제조] [Experimental Example 1-6: Preparation of oil-in-water cosmetic composition]
하기 표 2의 조성에 따라, 각 실험예의 수중유형 화장료 조성물을 제조하였다.According to the composition of Table 2 below, oil-in-water cosmetic compositions of each experimental example were prepared.
다공성 복합체 1: 제조예 1의 다공성 복합체 Porous Composite 1: Porous Composite of Preparation Example 1
다공성 복합체 2: 제조예 2의 다공성 복합체 Porous Composite 2: Porous Composite of Preparation Example 2
다공성 복합체 3: 제조예 3의 다공성 복합체 Porous Composite 3: Porous Composite of Preparation Example 3
다공성 복합체 4: 제조예 4의 다공성 복합체 Porous Composite 4: Porous Composite of Preparation Example 4
다공성 복합체 5: 제조예 5의 다공성 복합체Porous Composite 5: Porous Composite of Preparation Example 5
[물성 평가 1][Physical property evaluation 1]
각 실험예의 화장료 조성물의 제형 형성 유무, 점도, pH 및 경도를 측정하였다. pH는 기능성 화장품 시험 방법에 따라, 각 실험예의 화장료 조성물 2 g을 정제수 30 ml로 희석하여 pH 미터(Mettler Toledo)로 측정하였다. RTC-3005D 경도계를 사용하여, 측정바(속도 30 cm/min)로 10 mm 깊이로 눌렀을 때의 저항력을 측정하여 경도를 평가하였다. 상기 방법으로 측정된 각 물성을 하기 표 3에 나타내었다.Formulation formation, viscosity, pH and hardness of the cosmetic composition of each experimental example were measured. According to the functional cosmetic test method, 2 g of the cosmetic composition of each experimental example was diluted with 30 ml of purified water and measured using a pH meter (Mettler Toledo). Using an RTC-3005D hardness meter, hardness was evaluated by measuring resistance when pressed to a depth of 10 mm with a measuring bar (speed 30 cm/min). Each physical property measured by the above method is shown in Table 3 below.
상기 표 3에 나타난 바와 같이, 본 발명에 따른 다공성 복합체를 포함하는 실험예 1-5의 화장료 조성물은 분산성이 우수한 안정적인 제형을 형성하였고, 우수한 사용감과 도포를 제공할 수 있는 범위의 점도 및 경도를 나타내었다. 반면, 다공성 복합체 대신 티타늄디옥사이드와 실리카를 포함하는 실험예 6의 화장료 조성물은 제형을 형성하지 못하였을 뿐 아니라, 점도 및 경도가 지나치게 높게 나타났는데, 이는 화장료 조성물이 퍽퍽한 사용감 또는 불균일한 도포 등의 문제를 나타낼 수 있음을 의미한다.As shown in Table 3, the cosmetic composition of Experimental Examples 1-5 containing the porous composite according to the present invention formed a stable formulation with excellent dispersibility, and had a viscosity and hardness within a range capable of providing excellent feeling of use and application. showed On the other hand, the cosmetic composition of Experimental Example 6 containing titanium dioxide and silica instead of the porous composite not only failed to form a formulation, but also showed excessively high viscosity and hardness, which is due to the fact that the cosmetic composition has a stiff feeling of use or uneven application. This means that it can indicate a problem.
[물성 평가 2][Physical property evaluation 2]
각 실험예의 화장료 조성물을 사용하여, 사용감 등을 평가하였다. 화장품 평가/분석법 평-29에 근거하여 24시간 첩포 시험을 실시하였으며, 사용감 및 유연감은 가장 우수한 것을 5로, 이질감 및 피부 자극은 가장 적은 것을 5로 하여 5점 척도로 평가하였다. 평가 결과는 하기 표 4에 나타내었다. Using the cosmetic composition of each experimental example, the feeling of use and the like were evaluated. Based on the cosmetic evaluation/analysis method Pyeong-29, a 24-hour patch test was conducted, and the feeling of use and softness were evaluated on a 5-point scale, with 5 being the most excellent and 5 being the least heterogeneous and skin irritation. The evaluation results are shown in Table 4 below.
상기 표 4에 나타난 바와 같이, 티타늄 디옥사이드 함량 증가에 따라 피부 유연감에 대한 만족도가 낮아짐을 확인할 수 있으며, 실리카 함량 증가에 따라 제형 사용감에 대한 만족도가 높아짐을 확인할 수 있었다. As shown in Table 4, it can be confirmed that the satisfaction with the skin softness decreases with the increase in the titanium dioxide content, and the satisfaction with the feeling of use of the formulation increases with the increase in the silica content.
[물성 평가 3][Physical property evaluation 3]
하기 방법으로 각 실험예의 화장료 조성물의 자외선 차단 지수(SPF)를 측정하였다.The sun protection factor (SPF) of the cosmetic composition of each experimental example was measured by the following method.
자외선 투과율은 COLIPA(European Cosmetics Association)의 'method for the in vitro determination of UVA protection provided by sunscreen products' 시험 규격에 따라 측정하였다. 폴리메틸 메타크릴레이트 플레이트(PMMA 'HELIO PLATE HD6)에 각 실험예의 화장료 조성물 시료를 도포하고(도포량: 1.3 mg X 22 cm2 = 28.6 mg), UV-2000S(LABSPHERE, INC. USA)를 이용하여 290 내지 400 nm 영역의 투과율을 측정하였다. UV transmittance was measured according to the 'method for the in vitro determination of UVA protection provided by sunscreen products' test standard of COLIPA (European Cosmetics Association). A sample of the cosmetic composition of each experimental example was applied to a polymethyl methacrylate plate (PMMA 'HELIO PLATE HD6) (coating amount: 1.3 mg X 22 cm2 = 28.6 mg), and UV-2000S (LABSPHERE, INC. USA) was used to 290 to 400 nm region transmittance was measured.
상기 표 5에 나타난 바와 같이, 티타늄 디옥사이드의 함량이 높은 다공성 복합체를 포함하는 실험예 1, 4, 5의 조성물이 티타늄 디옥사이드의 함량이 상대적으로 낮은 다공성 복합체를 포함하는 실험예 2, 3의 조성물에 비하여 자외선 차단 효과가 큰 것을 확인할 수 있었다.As shown in Table 5, the compositions of Experimental Examples 1, 4, and 5 including porous composites having a high titanium dioxide content were compared to the compositions of Experimental Examples 2 and 3 including porous composites having a relatively low titanium dioxide content. In comparison, it was confirmed that the UV blocking effect was greater.
[물성 평가 4][Evaluation of physical properties 4]
하기 방법으로 각 실험예의 화장료 조성물의 역가 및 투명도를 측정하였다. The potency and transparency of the cosmetic composition of each experimental example were measured in the following manner.
각 실험예의 화장료 조성물을 4주 동안 1주일 간격으로 자외선 차단제의 역가를 측정하여, 자외선 차단제 안정성을 평가하였다. 1주일 간격으로 각 실험예의 화장료 조성물 샘플을 수거하여 제형 내 자외선 차단제를 HPLC로 분석하였고, 잔존량(백분율)을 역가로 평가하였다. 또한, 각 실험예의 화장료 조성물의 투명도를 육안으로 관찰하여, 투명하고 사용감이 우수할수록 높은 점수로 하여 5점 척도로 평가하였다. 평가 결과는 하기 표 6에 나타내었다. The cosmetic composition of each experimental example was evaluated for sunscreen stability by measuring the potency of the sunscreen agent at weekly intervals for 4 weeks. Samples of the cosmetic composition of each experimental example were collected at intervals of one week, and the sunscreen in the formulation was analyzed by HPLC, and the remaining amount (percentage) was evaluated by potency. In addition, the transparency of the cosmetic composition of each experimental example was observed with the naked eye, and evaluated on a 5-point scale with a higher score as the transparency and the feeling of use were excellent. The evaluation results are shown in Table 6 below.
상기 표 6에 나타난 바와 같이, 티타늄 디옥사이드의 함량이 높은 다공성 복합체를 포함하는 실험예 1, 4, 5의 조성물은 SPF 유지율이 우수하고, 티타늄 디옥사이드의 함량이 상대적으로 낮은 다공성 복합체를 포함하는 실험예 2, 3의 조성물은 투명도가 우수함을 확인할 수 있었다.As shown in Table 6, the compositions of Experimental Examples 1, 4, and 5 including porous composites having a high titanium dioxide content had excellent SPF retention and experimental examples including porous composites having a relatively low titanium dioxide content. It was confirmed that the compositions of 2 and 3 had excellent transparency.
[물성 평가 5][Evaluation of physical properties 5]
하기 방법으로 각 실험예의 화장료 조성물의 보습력을 평가하였다. 검정 인조 가죽을 일정한 온도 및 습도(온도 22±2°C, 상대습도 40± 2%)를 유지하는 항온 항습실에 약 20분 방치한 후, 각 실험예의 화장료 조성물을 2g씩 도포하여, 도포 전후의 수분 보유량을 측정하였다. 피부상태측정기(Cornneometer CM 825, C+k Co., 독일)를 이용하여, 도포 전, 도포 후 10분, 30분, 1시간에 수분 보유량을 측정하고, 하기 식 2로 보습 증가율을 계산하여, 그 결과를 하기 표 7에 나타내었다.The moisturizing power of the cosmetic composition of each experimental example was evaluated by the following method. After leaving the black artificial leather in a constant temperature and humidity room maintaining a constant temperature and humidity (temperature 22 ± 2 ° C, relative humidity 40 ± 2%) for about 20 minutes, 2 g of the cosmetic composition of each experimental example was applied, Water retention was measured. Using a skin condition measuring device (Cornneometer CM 825, C+k Co., Germany), the moisture retention was measured before application, 10 minutes, 30 minutes, and 1 hour after application, and the moisturizing increase rate was calculated by the following formula 2, The results are shown in Table 7 below.
[식 2][Equation 2]
보습 증가율(%) = (Ti-To)/Ti X 100Moisture increase rate (%) = (Ti-To)/Ti X 100
상기 식에서, In the above formula,
Ti는 제품 도포 후 피부 수분 보유량이고, Ti is the amount of moisture retained in the skin after application of the product,
To는 제품 도포 전 피부 수분 보유량이다.To is the amount of moisture retained in the skin before application of the product.
상기 표 7에 나타난 바와 같이, 티타늄 디옥사이드의 함량이 높은 다공성 복합체를 포함하는 실험예 1, 4, 5의 조성물은 티타늄 디옥사이드의 함량이 상대적으로 낮은 다공성 복합체를 포함하는 실험예 2, 3의 조성물에 비해 즉각적인 보습 효과가 우수하고, 수분 증발을 방지하며 지속적인 수분을 공급하는 효과도 우수함을 확인할 수 있었다.As shown in Table 7, the compositions of Experimental Examples 1, 4, and 5 including porous composites having a high content of titanium dioxide were compared to the compositions of Experimental Examples 2 and 3 including porous composites having a relatively low content of titanium dioxide. It was confirmed that the immediate moisturizing effect was excellent, and the effect of preventing moisture evaporation and continuously supplying moisture was excellent.
[자외선 차단용 크림 제조] [Production of sunscreen cream]
하기 표 8의 조성에 따라, 자외선 차단용 크림을 제조하였다.According to the composition of Table 8 below, a sunscreen cream was prepared.
Claims (7)
The cosmetic composition for sunscreen according to claim 1, comprising 0.1 to 15% by weight of the porous composite based on the total weight of the cosmetic composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220099163A KR102520887B1 (en) | 2022-08-09 | 2022-08-09 | Cosmetic composition for UV protection comprising porous composites |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220099163A KR102520887B1 (en) | 2022-08-09 | 2022-08-09 | Cosmetic composition for UV protection comprising porous composites |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102520887B1 true KR102520887B1 (en) | 2023-04-14 |
Family
ID=85946658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220099163A KR102520887B1 (en) | 2022-08-09 | 2022-08-09 | Cosmetic composition for UV protection comprising porous composites |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102520887B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102654855B1 (en) * | 2023-09-26 | 2024-04-04 | 한국콜마주식회사 | Cosmetic composition comprising complex powder |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180110960A (en) * | 2017-03-30 | 2018-10-11 | 한국과학기술원 | ROS-inhibiting, UV-screening composite particles and the use thereof |
KR20200137730A (en) * | 2019-05-31 | 2020-12-09 | 주식회사 씨티케이코스메틱스 | Uv blocking composite structure and method of preparing the same |
KR102216882B1 (en) * | 2020-09-08 | 2021-02-19 | 한국콜마주식회사 | Core-shell complex powder and composition for anti-inflammation or anti-oxidation comprising the same |
KR20220059822A (en) * | 2020-11-03 | 2022-05-10 | 아이큐어 주식회사 | Cosmetic composition for blocking ultraviolet lays and blue light |
-
2022
- 2022-08-09 KR KR1020220099163A patent/KR102520887B1/en active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180110960A (en) * | 2017-03-30 | 2018-10-11 | 한국과학기술원 | ROS-inhibiting, UV-screening composite particles and the use thereof |
KR20200137730A (en) * | 2019-05-31 | 2020-12-09 | 주식회사 씨티케이코스메틱스 | Uv blocking composite structure and method of preparing the same |
KR102216882B1 (en) * | 2020-09-08 | 2021-02-19 | 한국콜마주식회사 | Core-shell complex powder and composition for anti-inflammation or anti-oxidation comprising the same |
KR20220059822A (en) * | 2020-11-03 | 2022-05-10 | 아이큐어 주식회사 | Cosmetic composition for blocking ultraviolet lays and blue light |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102654855B1 (en) * | 2023-09-26 | 2024-04-04 | 한국콜마주식회사 | Cosmetic composition comprising complex powder |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100874802B1 (en) | Soluble film composition | |
KR101391834B1 (en) | Whitening cosmetic compounds and method for fabricating the same | |
KR101327943B1 (en) | Composition based on mineral concentrates derived for precious stones | |
US20070218021A1 (en) | Non-irritating sunscreen composition | |
CN109077952B (en) | Blue-light-resistant air cushion CC cream and preparation method thereof | |
KR101817081B1 (en) | Cosmetic composition comprising ginseng powders | |
KR20080090557A (en) | Clear sunscreen gels and methods of use thereof | |
KR102520887B1 (en) | Cosmetic composition for UV protection comprising porous composites | |
AU655790B2 (en) | Novel compositions | |
KR101870854B1 (en) | Cosmetic composition comprising complex of plant extracts | |
KR100377397B1 (en) | Skin care composition containing retinol and epidermal growth factor | |
KR101001287B1 (en) | Producing method for cosmetical compositions comprising hydroxy propyl cyclodextrin-resveratrol complex | |
EP3043770B1 (en) | Cosmetic compositions containing a combination of natural active ingredients | |
KR102081846B1 (en) | Mask pack compositions improved anti-wringkle effect | |
KR102354352B1 (en) | Oil-in- water cosmetic composition comprising physical sunscreen | |
KR20230149537A (en) | Solid lipid nanoparticles comprising 4-alkylresorcinol, cosmetic composition and cosmetics comprising the same | |
JP2004307434A (en) | Water-resistant o/w emulsion composition and water-resistant o/w cosmetic having ultraviolet prevention effect and containing water-resistant o/w emulsion composition therein | |
KR20210093498A (en) | Cosmetic composition containing thanake extract | |
KR102419912B1 (en) | Mist type sunscreen cosmetic composition | |
CN105997577B (en) | Gel-like oil-in-water type cosmetic | |
KR102104813B1 (en) | Skin irritation-free UV-blocking cosmetic composition containing cross-linked hyaluronic acid as an active ingredient | |
KR20040106616A (en) | Cosmetic Compositions Comprising Panax ginseng (C.A. MEY) Extract and Plant Extracts as Oriental Medicine for Preventing Skin Aging | |
KR102217874B1 (en) | Cosmetic Composition for Protecting UV and Adsorbing Fine Dust | |
JPH10130122A (en) | Skin cosmetic | |
KR20100033729A (en) | A cosmetic composition containing n-acetylglucosamine and vitamin c |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |